Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 426 | 619 | 1,127 | 1,324 | 853 |
| Cost of Goods | 341 | 438 | 512 | 1,071 | 678 |
| Gross Profit | 85 | 180 | 615 | 253 | 175 |
| Operating Expenses | 4,111 | 15,755 | 8,620 | 11,092 | 5,931 |
| Operating Income | -3,685 | -15,136 | -7,494 | -10,768 | -5,078 |
| Interest Expense | 229 | 160 | 0 | -1 | 96 |
| Other Income | 11 | 16 | 26 | 86 | 235 |
| Pre-tax Income | -3,902 | -15,280 | -7,468 | -10,681 | -4,939 |
| Net Income Continuous | -3,902 | -15,280 | -7,468 | -10,681 | -4,939 |
| Net Income | $-3,902 | $-15,280 | $-7,468 | $-10,681 | $-4,939 |
| EPS Basic Total Ops | -4.13 | -16.16 | -0.20 | -12.00 | -5.60 |
| EPS Basic Continuous Ops | -4.13 | -16.15 | -0.20 | -11.88 | -5.50 |
| EPS Diluted Total Ops | -4.13 | -16.16 | -0.20 | -12.00 | -5.60 |
| EPS Diluted Continuous Ops | -4.13 | -16.15 | -0.20 | -11.88 | -5.50 |
| EPS Diluted Before Non-Recurring Items | -4.00 | -16.00 | -8.00 | N/A | N/A |
| EBITDA(a) | $-3,556 | $-15,006 | $-7,250 | $-10,494 | $-4,800 |